Metronomic methotrexate + celecoxib versus cisplatin chemotherapy on health-related quality of life changes in patients with metastatic/relapsed or inoperable squamous cell cancer of the head and neck.
Phase of Trial: Phase III
Latest Information Update: 09 Aug 2014
Price : $35 *
At a glance
- Drugs Celecoxib (Primary) ; Cisplatin; Methotrexate
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 09 Aug 2014 New trial record
- 04 Jun 2014 HRQoL results presented at the 19th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes.